Fed. Trade Comm'n v. Boehringer Ingelheim Pharm., Inc.

892 F.3d 1264
CourtCourt of Appeals for the D.C. Circuit
DecidedJune 19, 2018
Docket16-5356; C/w 16-5357
StatusPublished
Cited by11 cases

This text of 892 F.3d 1264 (Fed. Trade Comm'n v. Boehringer Ingelheim Pharm., Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fed. Trade Comm'n v. Boehringer Ingelheim Pharm., Inc., 892 F.3d 1264 (D.C. Cir. 2018).

Opinions

Concurring opinion filed by Circuit Judge PILLARD.

KAVANAUGH, Circuit Judge:

The pharmaceutical company Boehringer claimed attorney-client privilege over certain documents subpoenaed by the Federal Trade Commission. The attorney-client privilege applies to a communication between attorney and client if at least "one of the significant purposes" of the communication was to obtain or provide legal advice. In re Kellogg Brown & Root, Inc. , 756 F.3d 754 , 758 (D.C. Cir. 2014). Under that standard, the attorney-client privilege applies to the documents at issue here. We affirm the judgment of the District Court.

I

A drug manufacturer that holds a patent has a market advantage. When a generic drug company challenges the validity of that patent, it threatens the patent holder's monopoly. Such a challenge can result in a settlement in which the patent holder pays the challenger to drop the challenge. That scenario is known as a "reverse payment" settlement-so labeled because the settlement requires the patent holder to "pay the alleged infringer, rather than the other way around." FTC v. Actavis, Inc. , 570 U.S. 136 , 141, 133 S.Ct. 2223 , 186 L.Ed.2d 343 (2013).

In Actavis , the Supreme Court analyzed the legality of reverse payments. If the payments are made simply to avoid litigation costs, they may be lawful. But if "the basic reason is a desire to maintain and to share patent-generated monopoly profits," then "the antitrust laws are likely to forbid the arrangement." Id. at 158 , 133 S.Ct. 2223 .

In 2008, a patent negotiation occurred between Boehringer (the name brand with the patent) and Barr (the generic seeking to challenge the patent). Ultimately, the parties reached a reverse payment settlement.

The Federal Trade Commission pays close attention to reverse payment settlements to ensure that they do not run afoul of antitrust law. In 2009, the Commission began investigating the Boehringer-Barr settlement. During the investigation, the Commission subpoenaed documents from Boehringer. Boehringer claimed that the subpoenaed documents were created by Boehringer employees for Boehringer's general counsel, Marla Persky, at her request. The documents allowed Persky to analyze and navigate the treacherous antitrust issues surrounding reverse payment settlements. Other documents reflected communications between Persky and Boehringer executives regarding the possible settlement. Boehringer asserted attorney-client privilege over the documents.

The burden is on the proponent of the privilege to demonstrate that it applies. See United States v. Legal Services for New York City , 249 F.3d 1077 , 1081 (D.C. Cir. 2001). In a thorough and careful opinion, the District Court agreed with Boehringer that the documents at issue here are covered by the attorney-client privilege. To the extent the Commission challenges the legal test employed by the District Court, our review is de novo. To the extent the Commission challenges the facts found by the District Court, our review is for clear error.

II

As relevant here, the attorney-client privilege applies to a confidential communication between attorney and client if the communication was made for the purpose of obtaining or providing legal advice. See Upjohn Co. v. United States , 449 U.S. 383 , 101 S.Ct. 677 , 66 L.Ed.2d 584 (1981) ; In re Kellogg Brown & Root, Inc. , 756 F.3d 754 , 757 (D.C. Cir. 2014). The privilege covers both (i) those communications in which an attorney gives legal advice; and (ii) those communications in which the client informs the attorney of facts that the attorney needs to understand the problem and provide legal advice.

In the corporate context, the attorney-client privilege applies to communications between corporate employees and a corporation's counsel made for the purpose of obtaining or providing legal advice. The privilege applies regardless of whether the attorney is in-house counsel or outside counsel.

The application of the attorney-client privilege can become more complicated when a communication has multiple purposes-in particular, a legal purpose and a business purpose. In this case, for example, the communications had a legal purpose: to help the company ensure compliance with the antitrust laws and negotiate a lawful settlement. But the communications also had a business purpose: to help the company negotiate a settlement on favorable financial terms.

In a situation like this where a communication has multiple purposes, courts apply the "primary purpose" test to determine whether the communication is privileged. See Kellogg , 756 F.3d at 759 . In Kellogg , this Court recently explained that courts applying the primary purpose test should not try "to find the one primary purpose" of a communication. Attempting to do so "can be an inherently impossible task" when the communications have "overlapping purposes (one legal and one business, for example)." Id. "It is often not useful or even feasible to try to determine whether the purpose was A or B when the purpose was A and B."

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
892 F.3d 1264, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fed-trade-commn-v-boehringer-ingelheim-pharm-inc-cadc-2018.